Poseidon Asset Management
Fund providing access to a diverse range of companies in the cannabis industry.
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Poseidon Asset Management.
Fund providing access to a diverse range of companies in the cannabis industry.
Key people at Poseidon Asset Management.
Key people at Poseidon Asset Management.
Poseidon Asset Management is a pioneer hedge fund and venture capital firm dedicated exclusively to the cannabis industry, offering specialized investment funds tailored for accredited investors seeking exposure to marijuana and hemp businesses.[1][4] Founded by siblings Emily and Morgan Paxhia, the firm operates as one of the longest-running dedicated cannabis investment funds, bringing institutional capital and expertise to an industry historically starved of mainstream financial support.[4] The firm's investment philosophy centers on identifying and supporting licensed cannabis operators and ancillary businesses—from cultivation and retail to point-of-sale software and related services—recognizing that the cannabis sector requires specialized knowledge and patient capital to navigate regulatory complexity and market volatility.
Poseidon's impact on the startup ecosystem has been substantial, particularly in legitimizing cannabis as an investable asset class during a period when most traditional venture capital firms avoided the sector entirely. By deploying capital into 41 portfolio companies across cannabis and adjacent software sectors, the firm has helped establish professional standards for cannabis business operations while simultaneously building a network of founders, operators, and service providers that strengthens the broader industry.[2] The firm's track record shows a 19 percentage point higher exit rate compared to peer organizations, demonstrating both operational acumen and the ability to identify winning investments in a nascent market.[2]
Emily and Morgan Paxhia founded Poseidon Asset Management in 2013 in San Francisco, California, positioning themselves at the forefront of cannabis investment during a transformative period for the industry.[4] The timing of their entry was strategic—just as California and other states began implementing regulated medical cannabis frameworks, creating the first legitimate opportunity for institutional investment in the space. Rather than viewing cannabis as a speculative or controversial sector, the Paxhias recognized it as an emerging industry requiring professional capital, operational expertise, and long-term commitment.
The firm's evolution reflects the maturation of cannabis markets themselves. Poseidon launched its first fund in 2013, followed by a second fund, with both eventually closing to new investors as the firm refined its strategy.[1] The launch of the Poseidon Garden Fund in March 2021 represented a deliberate expansion, opening investment opportunities to a broader pool of accredited investors while maintaining the firm's selective, thesis-driven approach.[7] This progression demonstrates how Poseidon has adapted its product offerings to meet changing market conditions and investor demand, even as the broader cannabis industry faced headwinds from regulatory uncertainty and market consolidation.
Poseidon's founding in 2013 positioned the firm as a pioneer in cannabis investment, accumulating over a decade of operational knowledge and industry relationships that newer entrants cannot easily replicate. The firm's deep understanding of cannabis regulatory frameworks, licensing requirements, and operational challenges gives it a significant edge in identifying viable investments and supporting portfolio companies through complex compliance landscapes.
Rather than pursuing a spray-and-pray approach, Poseidon demonstrates disciplined capital deployment. The firm typically participates in 2-6 deals annually, with a strong preference for companies in the 2-3 year maturity range and deals sized between $10-50 million.[2] This selectivity, combined with a 19 percentage point higher exit rate than peer organizations, suggests the firm has developed reliable pattern recognition for identifying cannabis businesses with genuine staying power.[2]
While cannabis represents the core focus with 32 of 41 portfolio investments in the sector, Poseidon also maintains meaningful exposure to software (23 investments), SaaS (19 investments), and information technology (11 investments).[2] This diversification into ancillary services—particularly point-of-sale systems and business software—creates a portfolio ecosystem where companies can serve one another, amplifying network effects and creating multiple paths to value creation.
As managing partners of a respected cannabis investment fund, Emily and Morgan Paxhia have built substantial credibility within the industry. Their involvement signals legitimacy to other investors and helps portfolio companies attract follow-on capital from firms like Phyto Partners, Salveo Capital, and Arcview Group, which frequently co-invest in Poseidon-backed rounds.[2]
Poseidon operates at the intersection of several powerful macro trends: the gradual legalization and normalization of cannabis across North America, the professionalization of cannabis businesses, and the growing recognition that cannabis represents a legitimate consumer and B2B market requiring sophisticated infrastructure.
The firm's existence and track record directly challenge the stigma that has historically prevented mainstream venture capital from engaging with cannabis. By demonstrating that cannabis businesses can generate substantial returns and achieve successful exits, Poseidon has helped shift institutional investor sentiment. This is particularly significant given that federal prohibition has created a unique market dynamic where cannabis companies cannot access traditional banking, cannot deduct ordinary business expenses under Section 280E of the tax code, and operate in a patchwork of state-level regulatory regimes.[1] Poseidon's ability to navigate these constraints and still identify profitable investments demonstrates sophisticated deal-making in an asymmetric information environment.
The firm's portfolio construction—blending pure cannabis operators with software and SaaS companies—reflects a deeper understanding of how the cannabis industry will mature. As cannabis markets consolidate and competition intensifies, the real value creation increasingly flows to companies providing compliance software, point-of-sale systems, supply chain management, and other infrastructure services. Poseidon's diversification into these ancillary sectors positions its portfolio to benefit from industry professionalization and consolidation.
However, Poseidon's experience also illuminates the challenges facing cannabis investment. The firm's AdvisorShares Poseidon Dynamic Cannabis ETF (ticker: PSDN), launched in November 2021, declined by nearly 90% before shutting down in August 2023, reflecting broader headwinds including falling wholesale prices, slow federal reform, and dwindling retail investor interest in cannabis stocks.[3] This outcome underscores that even experienced cannabis investors face significant macroeconomic and policy headwinds that can overwhelm strong operational execution.
Poseidon Asset Management stands at a critical juncture. The firm has successfully established itself as a credible, long-term player in cannabis investment with a track record of identifying winners and supporting their growth. However, the cannabis industry itself faces structural challenges: federal prohibition continues to constrain access to capital and banking services, state-level regulatory fragmentation creates operational complexity, and wholesale price compression has squeezed margins across the supply chain.
The firm's future likely depends on several factors. First, federal cannabis reform—particularly the removal of Section 280E tax penalties and clarification of banking access—could unlock substantial value for portfolio companies and attract mainstream institutional capital, validating Poseidon's long-term thesis. Second, the firm's focus on ancillary software and services may prove more resilient than pure cultivation and retail, as infrastructure companies typically command higher margins and face fewer regulatory constraints. Third, consolidation within cannabis could create exit opportunities for Poseidon's portfolio companies, as larger operators seek to acquire specialized capabilities and market share.
Looking ahead, Poseidon's influence on the broader startup ecosystem will likely grow if federal reform materializes. The firm has already demonstrated that cannabis can be a legitimate venture asset class; if regulatory barriers fall away, the firm's accumulated expertise and network could position it as a bridge between traditional venture capital and cannabis entrepreneurs. Conversely, if federal prohibition persists and state-level markets continue to face margin compression, Poseidon may increasingly focus on ancillary services and infrastructure plays rather than pure cannabis operators—a strategic pivot that would reshape its identity but potentially improve long-term returns.
The firm's journey ultimately reflects a broader truth about emerging industries: first-mover advantage and operational excellence matter, but macroeconomic and policy forces can overwhelm even the best-executed investment theses. Poseidon's next chapter will reveal whether patient capital and specialized expertise can overcome structural headwinds in the cannabis sector.
